Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jul 28, 2014; 20(28): 9513-9518
Published online Jul 28, 2014. doi: 10.3748/wjg.v20.i28.9513
Published online Jul 28, 2014. doi: 10.3748/wjg.v20.i28.9513
Figure 1 Liver-to-body weight ratio in mice fed a normal or lithogenic diet.
Figure 2 Cav3 and Cckar mRNA in the gallbladder (A) and liver (B) of both control and cholesterol gallstone disease mice.
Figure 3 Western blotting for caveolin-3 and cholecystokinin A receptor in the gallbladder of both control and cholesterol gallstone disease mice.
CAV3: Caveolin-3; GAPDH: Glyceraldehyde-3-phosphate dehydrogenase.
Figure 4 Western blotting for caveolin-3 in the liver of control and cholesterol gallstone disease mice.
CCKAR: Cholecystokinin A receptor; CAV3: Caveolin-3; GAPDH: Glyceraldehyde-3-phosphate dehydrogenase.
- Citation: Xu GQ, Xu CF, Chen HT, Liu S, Teng XD, Xu GY, Yu CH. Association of caveolin-3 and cholecystokinin A receptor with cholesterol gallstone disease in mice. World J Gastroenterol 2014; 20(28): 9513-9518
- URL: https://www.wjgnet.com/1007-9327/full/v20/i28/9513.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i28.9513